Theraclion

At Theraclion we believe that surgery, as we know it, is outdated. It converts optimistic patients into anxious individuals, brilliant doctors into exhausted system executors and stretches healthcare systems to the limit. We have disrupted this convention by creating extracorporeal treatment platforms. We replace surgery with a robotic treatment from outside the body using High Intensity Focussed Ultrasound (HIFU). Our leading edge echotherapy platforms are currently CE marked in non-invasive treatment of varicose veins with SONOVEIN® and of breast fibroadenomas and thyroid nodules with Echopulse®. Located in Malakoff, near Paris, our employees live and breath innovation by extensive clinical research and harness artificial intelligence to reshape surgery by making non-invasive echotherapy the new standard. Located in Malakoff, near Paris, Theraclion brings together a team of 25 people, more than half of whom are dedicated to R&D and clinical trials.

Company’s Keywords:

high intensity focused ultrasound, breast fibroadenoma, echopulse, echotherapy, medical device, sonovein, varicose veins, thyroid nodules, medtech